LH-RH agonists/GnRH agonists for prostate cancer

References

Citations

1. Bolla M, et al. (2002). Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial. Lancet, 360(9327): 103–108.

2. National Cancer Institute (2006): Prostate Cancer (PDQ): Treatment—Health Professional Version. Available online: http://www.nci.nih.gov/cancertopics/pdq/treatment/prostate/HealthProfessional.

3. Schröder FH (2002). Hormonal therapy of prostate cancer. In PC Walsh et al., eds., Campbell's Urology, 8th ed., vol. 4, pp. 3182–3208. Philadelphia: W.B. Saunders.

4. Famili P, et al. (2007). The effect of androgen deprivation therapy on periodontal disease in men with prostate cancer. Journal of Urology, 177(3): 921–924.

5. Hellerstedt BA, Pienta KJ (2002). The current state of hormonal therapy for prostate cancer. CA—A Cancer Journal for Clinicians, 52: 154–179.

Author:	Douglas Dana Kathe Gallagher, MSW	Last Updated: November 22, 2006
Medical Review:	Martin Gabica, MD - Family Medicine Adam Husney, MD - Family Medicine J. Curtis Nickel, MD, FRCSC - Urology Christopher G. Wood, MD, FACS - Urology/Oncology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.